Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Letter to the editor

He who seeks (more) finds

    • Infectiology
    • News
    • Pneumology
    • RX
  • 1 minute read

The number of new infections is a key indicator of a possible easing of the lockdown – it just needs to be interpreted correctly.

The number of new COVID-19 infections is a key indicator of whether the lockdown should be relaxed or continue at its current level after April 19.

However, the numbers of newly infected persons published by the FOPH can only be correctly assessed in relation to the SARS-CoV-2 tests performed per time unit. Out of 150,000 tests performed so far, approximately 21,000 tests have been returned as “positive”. In international comparison, Switzerland carries out many tests, in the meantime also within the framework of home or drive-in testing. Therefore, assuming that more and more corona tests are performed per day, the alleged “stable number” of newly infected persons (ca 1000/day) would de facto be an actual relative decrease of newly infected persons (=calming).

In addition to the economic consequences of the continuation of the current lockdown, there is currently also a great danger in Switzerland that non-COVID-19 patients will be medically under-cared for, and this despite the fact that the majority of Swiss hospitals are currently 50-70% empty and the associated medical staff have nothing to do.

Prof. Dr. med Paul Mohacsi, eMBA UZH, Herrliberg

 

© NZZ

 

Previous Article
  • Breast Cancer

Breast cancer screening for everywoman?

  • Education
  • Gynecology
  • News
  • Oncology
  • RX
  • Studies
View Post
Next Article
  • Prevention campaign

It is important to detect cardiovascular diseases and osteoporosis at an early stage!

  • Cardiology
  • Congress Reports
  • General Internal Medicine
  • Geriatrics
  • Market & Medicine
  • Orthopedics
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • cSCC: Personalizing Treatment Strategies and Follow-up Care Plans

Comprehensive risk stratification is no simple matter: what’s new?

    • RX
    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • Studies
View Post
  • 12 min
  • Baxdrostat – a new class of drugs for treating difficult-to-control hypertension

First Aldosterone Synthase Inhibitor Is Here

    • RX
    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 3 min
  • Geriatric Small-Cell Lung Cancer

Therapeutic Challenges

    • RX
    • Education
    • Geriatrics
    • Oncology
    • Pneumology
    • Studies
View Post
  • 8 min
  • Chronic Pruritus in Renal, Hepatic, and Biliary Tract Diseases

Pooled Expertise for Targeted Evaluation and Treatment

    • RX
    • Dermatology and venereology
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 6 min
  • Advanced Thyroid Cancer

Molecular Mechanisms and New Therapeutic Approaches

    • RX
    • Education
    • Endocrinology and Diabetology
    • Oncology
View Post
  • 4 min
  • Epidermolysis bullosa

Promoting Wound Healing with Gene Therapies and Birch Bark Extract

    • RX
    • Dermatology and venereology
    • Education
    • Genetics
    • Pediatrics
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 18 min
  • From Risk Identification to Anti-Inflammatory Intervention

Inflammation as a Treatment Goal in Its Own Right

    • RX
    • Angiology
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Studies
View Post
  • 3 min
  • Psoriasis Research: What's in the Pipeline?

Highly selective oral TYK inhibitors in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.